ESMO21

Aprea Therapeutics Stock Jumps After Eprenetapopt Combo Data Presentation At ESMO

AstraZeneca's Enhertu Posts Substantial Clinical Benefit Over Roche's Kadcyla In Breast Cancer Trials

Syros Posts Updated Data From CDK7 Inhibitor In Various Solid Tumor Settings

AstraZeneca's Enhertu Posts Substantial Clinical Benefit Over Roche's Kadcyla In Breast Cancer Trials

Syros Posts Updated Data From CDK7 Inhibitor In Various Solid Tumor Settings

Exelixis's Cabometyx Scores FDA Nod In Differentiated Thyroid Cancer; ESMO Presentation

Why Are BeyondSpring's Shares Plunging Today?

Exelixis's Cabometyx Scores FDA Nod In Differentiated Thyroid Cancer; ESMO Presentation

Why Are BeyondSpring's Shares Plunging Today?

Novartis' Kisqali Combo Therapy Extends Survival By One Year In Breast Cancer Patients

AstraZeneca Touts Longest Survival Update In Lung Cancer Setting With Imfinzi/Chemo Data

ESMO21 Recent News

Mirati Unveils Long-term Survival Data For Sitravatinib/Nivolumab Combo In Lung Cancer Patients

Mirati Posts Adagrasib Data In KRAS-Mutated Lung Cancer, FDA Filing Now On The Cards

Mirati Showcases New KRAS Drug Data In Colorectal Cancer At ESMO

Merck Backs Up Keytruda Approval In TNBC With Encouraging Overall Survival Data

Verastem Shares Are Trading Higher On Encouraging Combo Therapy Data At ESMO Presentation

Seagen, Genmab Present Tisotumab Vedotin Combo Data In Cervical Cancer

Sanofi, Regeneron, Share Competitive Libtayo Survival Data in 1L NSCLC

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA (NASDAQ: SNY) hope to expand Libtayo into a broader population with a chemo combo regimen.

AstraZeneca-Daiichi Sankyo Share Detailed Enhertu Data In Gastric Cancer

Janssen Shares Erdafitinib Combo Therapy Data In Bladder Cancer

TCR2 Therapeutics Stock Plunges On Safety Signals From Gavo-cel Solid Tumor Trial

TCR2 Therapeutics Inc (NASDAQ: TCRR) stock dropped to a 52-week low after interim results from the ongoing Phase 1 portion of the gavo-cel Phase 1/2 trial for mesothelin-expressing solid tumors.

Deciphera Presents New Data Across Pipeline At ESMO Congress

Corcept Therapeutics' Relacorilant Combo Therapy Shows Clinical Benefit In Ovarian Cancer

What Is Happening With Innate Pharma Stock On Friday?

Gritstone Presents Data From Individualized Neoantigen Immunotherapy In Colorectal Cancer

Junshi Biosciences, Coherus Share Toripalimab Survival Data In Esophageal Cancer

Shanghai Junshi Biosciences Co Ltd and Coherus BioSciences Inc (NASDAQ: CHRS) announced interim results from the Phase 3 JUPITER-06 trial.

Novartis' Prostate Cancer Therapy Linked To Improved Quality Of Life

Novartis AG (NYSE: NVS) is building the case for its radioligand therapy, 177Lu-PSMA-617.

Agenus' Combo Therapy Trial Shows Higher Responses In Cervical Cancer

Ayala Pharma Unveils New Interim Data From Rare Cancer Trial With AL101

NGM Bio Presents Preliminary Data From NGM120 Solid Tumor Trial

Aileron Stock Is Trading Lower After Data Presentation For Chemoprotective Agent

MacroGenics Shares Fall After MGC018 Data Fails To Impress At ESMO Presentation

MacroGenics Inc (NASDAQ: MGNX)

Bristol Myers Touts 5-Year Kidney Cancer Data For Opdivo-Yervoy Combo Therapy

Gilead Churns Out Additional Trodelvy Data